Skip to main content
Nutrient Wise Logo Nutrient Wise
  • Features
  • Library
  • Pricing
  • FAQ
Download App

← All Ingredients

The Complete Ingredient Breakdown

Iceland Moss

Published November 16, 2026 · Last reviewed November 16, 2026 · 7,049 words · Holding supplement companies to a cleaner and higher standard

The bottom line

Bottom Line

Taking medication? The free Nutrient Wise app warns you if Iceland Moss interacts with what you already take — before you buy it. 5 free scans a month, no card needed.

Get it on the App Store Get it on Google Play

In this breakdown
  1. What is Iceland Moss?
  2. What the Label Won't Tell You
  3. Primary Functions & Benefits
  4. Forms & Standardization
  5. Food Sources
  6. Who Should Take Iceland Moss
  7. Who Should AVOID or Use Caution
  8. Recommended Dosages
  9. Timing & Administration
  10. Timeline of Effects
  11. Benefits of Taking Iceland Moss
  12. Potential Negatives & Side Effects
  13. Deficiency Symptoms
  14. Toxicity Symptoms
  15. How Iceland Moss Works
  16. Synergistic Supplements
  17. Interactions & What NOT to Take
  18. Quality, Testing & Adulteration
  19. Special Considerations
  20. Research Status & Evidence Quality
  21. Summary & Key Takeaways

What is Iceland Moss?

Iceland moss is not a moss. Cetraria islandica is a lichen, and 25 to 50% of its dry weight is polysaccharide, mostly lichenan and isolichenan. That figure comes from the European Medicines Agency's 2014 assessment report (EMA/HMPC/36866/2014), and it explains nearly everything the product is sold for: soaked in water, the thallus swells into a slippery gel that coats a dry throat.

A lichen is a partnership between a fungus and a photosynthetic partner, living as one body. Cetraria islandica grows on the ground as a branching, leafy thallus up to about 15 cm long, greenish to brown on top and whitish to brownish underneath, across northern and eastern Europe, Siberia and North America, and in mountain sites farther south such as the Alps. It has no roots, no cuticle and no way to filter what lands on it. It takes water and minerals straight from rain, fog and dust. That last fact matters as much as the polysaccharide content, and it is the reason this issue spends real space on lead and cesium.

The drug sold in pharmacies is the dried thallus, listed in the European Pharmacopoeia (monograph 1439) as Lichen islandicus. It reaches buyers three ways: as a cut, dried herb for tea; as an aqueous soft extract pressed into gum-arabic lozenges, the form behind the German Isla range (the EMA records lozenges of this extract type on the German market since at least 1976); and as a scattering of capsules, syrups, tinctures and food uses. Icelandic cooking puts it in porridge, soup, sausage and skyr, and Northern European famines turned it into bread.

Common Names

Iceland moss, Iceland lichen, Icelandic moss, Lichen islandicus (pharmacopoeial Latin), Isländisch Moos (German), fjallagrös (Icelandic). The sister species Cetraria ericetorum is so similar that the two are often grouped as the Cetraria islandica species complex.

Primary Active Compounds

  • Lichenan, a beta-1,3/1,4-glucan that dissolves in hot water

  • Isolichenan, an alpha-glucan that dissolves in cold water, molecular weight about 6 to 8 kD

  • Fumarprotocetraric acid, 2.6 to 11.5% depending on collection site

  • Protolichesterinic acid, 0.1 to 1.5%, a bitter paraconic acid

  • Protocetraric acid, 0.2 to 0.3%

  • Usnic acid, absent in two analyses and found at 0.04% in a third

Key Note

The same lichen extract reaches shelves under three rulebooks: as a registered traditional herbal medicine, as a medical-device lozenge, and as a dietary supplement. Only the first is bound by the EMA monograph's indications, age floors and duration limit, so the regulatory category printed on the pack matters as much as the extract amount.

What follows covers what the lozenges actually contain, what three small clinical studies found, and what a lichen with no cuticle collects from the air it lives in.

Scan any Iceland Moss product in seconds with the free NutrientWise app: App Store · Google Play

What the Label Won't Tell You

Europe's medicines regulator has assessed Iceland moss and accepted it for exactly two things: soothing an irritated mouth or throat with dry cough, and temporary loss of appetite in adults. The EMA's herbal committee granted only traditional-use status in its monograph (EMA/HMPC/678891/2013, published February 2015), because its assessors judged the clinical studies too small and found none with a placebo arm. A 2021 review found no new clinical data. The lozenge use carries a six-year age floor and a one-week limit without medical advice. The second problem is what the lichen collects from the air. The European Pharmacopoeia standard cited by the EMA lets Iceland moss carry 10 ppm of lead, double the 5 ppm default for herbal drugs. Raw lichen from southern Finland held 30 mg/kg of lead (reported 1986), finished products bought in Italy averaged 9.25 mg/kg (published 2017), and wild Estonian thalli held 6,200 Bq/kg of cesium-137 in 1986.

Primary Functions & Benefits

Demulcent for mouth and throat irritation with dry cough

This is the use the EMA monograph accepts first, and the one every lozenge is built around. Lichenan and isolichenan hydrate into a viscous film that sits on the mucosa while a lozenge dissolves or a cup of tea is sipped. The European Pharmacopoeia sets a minimum swelling index of 4.5 for powdered Iceland moss, which is a quality test for exactly this property: how much the drug swells in water. The monograph's wording is symptomatic relief of oral or pharyngeal irritation and associated dry cough. It is not a cough suppressant in the pharmacological sense and the monograph does not claim it treats infection.

Temporary loss of appetite

The second indication is adults only. The HMPC considered it plausible because of the bitter taste of the lichen acids, chiefly protolichesterinic and fumarprotocetraric acid. Bitter substances on the tongue are the classic rationale for appetite-stimulating "bitters" in European herbal practice. No clinical study of Iceland moss for appetite is cited in the assessment report. The indication rests on its appearance in handbooks and pharmacopoeias for more than 30 years, which is the 30-year evidence test for traditional-use registration under Directive 2001/83/EC.

What the laboratory work shows, and what it does not

The assessment report lists immunomodulating, antimicrobial, anti-inflammatory, antioxidant and antiproliferative findings, all in cell cultures or animals. An aqueous extract raised granulocyte phagocytosis by 92.6% at 100 micrograms per ml in vitro (Ingólfsdóttir, 1998). Protolichesterinic acid inhibited Helicobacter pylori at 16 to 64 micrograms per ml across 35 clinical strains. Ethanol extract suppressed A/H3N2 and A/H5N1 influenza replication in MDCK cells by 3.5 and 4 log at 50 micrograms per ml (Makarevich, 2023). The EMA report states plainly that a direct link to clinical use cannot be drawn from these studies. None of them supports buying Iceland moss for immunity, ulcers or viral infection.

Traditional uses outside the monograph

Iceland moss has been used for gastric and duodenal ulcers in Iceland, for colds in Finland, as a laxative and cough remedy in Central Europe, for nephritis and diabetes in Sweden, and for tuberculosis in Spain, France and Turkey, according to a 2022 review of the genus in Molecules (Sánchez and colleagues). These are historical records, not evidence of benefit, and the EMA did not accept any of them as indications.

Forms & Standardization

Iceland moss is never standardized to a marker compound the way a ginkgo or St. John's wort extract is. Products are defined by the drug-to-extract ratio (DER) and the extraction solvent, and almost every studied product uses water. The EMA assessment and its tables of marketed products give the clearest map of what exists.

Comminuted herbal substance (cut, dried thallus)

This is the tea form and the only form with a fixed herb amount on the label. The monograph allows it as an infusion or a cold macerate for throat irritation and as an infusion or decoction for appetite. The difference matters chemically: isolichenan dissolves in cold water and lichenan needs hot water, so a cold macerate and a decoction pull different polysaccharide profiles from the same lichen. The monograph says a macerate should be used immediately after preparation. Poland has marketed the cut herb as a decoction product since 2000 at 2.5 to 4.0 g in 300 ml of water.

Soft extract, DER 0.4 to 0.8:1, water

This is the extract in the classic Isla-Moos pastille. A 2014 Austrian leaflet for isla moos, which labels the pastille a medical device (Medizinprodukt), lists 80 mg of aqueous extract (0.4 to 0.8:1) per pastille in a base of gum arabic, liquid paraffin, caramel color and 424 mg of sucrose. The EMA's product table lists German lozenges of this extract type at 80 or 160 mg on the market as medicines from 1976 to December 31, 2010. This extract type was used in the largest safety study (Isla-Moos, n = 1,848 children). The Vorberg 1981 open study used a different pastille, 160 mg of aqueous extract plus 5 mg of hogweed (Heracleum sphondylium) extract, with no DER stated in the EMA summary.

Soft extract, DER 2 to 4:1, water

A more concentrated aqueous extract, sold as a 100 mg oral gum or lozenge. In the Hecker and Völp 2004 surveillance study this was the Isla-Mint lozenge (n = 1,295 children). The EMA records 100 mg lozenges of this type in Slovenia since 2000.

Soft extract, DER 16 to 18:1, water (syrup)

Syrups at 6 mg of extract per ml have been sold in Slovenia since 2012 and in Latvia and Hungary since 2013. The HMPC excluded this preparation from the monograph because its traditional-use data are not in the public domain. A syrup bottle at this ratio is outside what the EU monograph covers.

Tincture 1:5, ethanol 40% (V/V)

Included in the monograph for adults only (18 and over), on the strength of the British Herbal Pharmacopoeia. It is the one ethanol preparation in the monograph.

Dry extract, DER 30 to 40:1

The Slovenian company Krka sells a lozenge with 3 mg of dry Iceland moss extract at this ratio. Its only published data are a 2026 company consumer test, covered under Benefits. A 3 mg dose of a 30 to 40:1 extract corresponds to roughly 90 to 120 mg of lichen, but the ratio says nothing about which constituents survived drying.

Medical-device lozenges

Some current Isla products are not medicines at all. The isla med akut Zitrus-Honig leaflet (version dated March 2019) classifies the lozenge as a medical device (Medizinprodukt), not a medicine. Each lozenge carries 80 mg of aqueous Iceland moss extract plus 102 mg of a hydrogel complex (carbomer, xanthan gum, sodium hyaluronate), sweetened with sorbitol, maltitol and acesulfame K. A device is regulated for a physical film-forming action, so the EMA monograph and its age limits do not formally apply to it.

Capsules and powders

Capsules of powdered thallus are also sold as dietary supplements. None of the clinical or surveillance data above used a capsule. Swallowing powdered lichen bypasses the mouth and throat entirely, so the one mechanism the monograph accepts (a film on the irritated mucosa) does not apply to a capsule.

Which form the human data used

All three clinical datasets (Kempe 1997, Vorberg 1981, Hecker and Völp 2004) used aqueous soft extracts in pastilles or lozenges. None of the human studies the EMA assessed used tea, tincture, syrup or capsules.

Food Sources

Iceland moss is one of the few medicinal lichens with a genuine food history, and the food record carries its own warning.

Iceland

The Sánchez 2022 review records Icelandic recipes using the lichen in soups, porridges and sausages, and added to skyr, plus a bitter schnapps at 38% alcohol. In Italy it is sold as a food supplement valued for digestion.

Famine food in Northern Europe

Northern European households baked the lichen into bread during famines, sometimes mixed with rice or flour. In Russia in 1942 to 1943 it was used to extract glucose industrially when beet sugar ran short. Boiling and soaking in wood ash were the traditional pretreatments. In a 1986 study of Finnish famine foods, Airaksinen and colleagues fed mice diets containing 50% Iceland moss: untreated lichen killed the mice within 4 to 5 days, and boiling plus soaking in wood ash extended survival to 20 to 22 days. Rats fed a 25% ash-treated lichen diet for 3 months developed proteinuria and kidney tubule changes that the authors attributed probably to the high lead content of the lichen. The traditional ash-and-boil treatment existed for a reason.

Flavoring use in the US

US federal rules list Iceland moss among natural flavoring substances under 21 CFR 172.510 with a single limitation, "in alcoholic beverages only." It is not listed for use in other foods under that section.

Is dietary intake realistic or sufficient?

There is no nutrient in Iceland moss that anyone needs, so "sufficient" does not apply. The relevant number is contamination per gram eaten, and food-scale intake (a famine bread or a porridge at tens of grams of lichen) multiplies the metal and radionuclide load of a 1.5 g tea serving many times over. Nobody outside a few Icelandic dishes eats it as food today.

Who Should Take Iceland Moss

Adults and older children with a dry, irritated throat and a dry cough

This is the monograph population. The typical triggers named on Isla leaflets are dry heated or air-conditioned air, heavy voice use by singers and speakers, mouth breathing with a blocked nose, and the scratchy throat of a cold. The EMA public summary limits the demulcent use to adults, adolescents and children over 6 years. For the cut herb as tea, the assessment report sets the floor higher, at 12 years, for lack of data in younger children.

Mouth breathers after nasal surgery, under their surgeon's care

The one randomized trial in the EMA assessment (Kempe 1997, Kaiserslautern) enrolled patients whose noses were packed after septum surgery. If an ENT team offers Iceland moss pastilles in that setting, the trial supports the use for mucosal dryness during the packed-nose days.

Adults with a short-term loss of appetite

The monograph's second indication is adults only, as tea, for no longer than one week without medical advice. Appetite loss that persists, or that comes with weight loss, is a symptom to have examined rather than a reason to keep drinking bitters.

Who gains nothing

Anyone buying capsules for immunity, ulcers, lung health or detoxification. None of those uses is in the monograph, and the in vitro data behind them have never been tested in people.

Who Should AVOID or Use Caution

Contraindications

  • Hypersensitivity to Iceland moss or any lichen. This is the only contraindication in the EMA assessment.

  • Children under 6 years for lozenges, under 12 years for the tea, and under 18 years for the tincture or for the appetite indication.

  • Pregnancy and breastfeeding. The EMA assessment does not recommend use because safety has not been established and no fertility data exist. This conflicts with the 2014 Austrian isla moos leaflet (a medical-device label), which states that no findings argue against use in pregnancy and breastfeeding. The regulator's position is the cautious one, and it is the one to follow.

Use Caution

  • People with photosensitive dermatitis. In patch tests of 45 such patients with lichen mixtures (Thune and Solberg, 1980), 16 reacted. Tests with Cetraria islandica produced 8 positive reactions, and in 6 patients reactions grew stronger after ultraviolet exposure, suggesting photoallergy.

  • People with diabetes or sugar intolerance. A classic isla moos pastille contains 424 mg of sucrose; ten a day add 4.2 g of sugar. The leaflet asks people with known sugar intolerances to consult a doctor first.

  • Anyone prone to loose stools using sugar-free versions. The isla med akut leaflet warns that excessive use can have a laxative effect from sorbitol and maltitol.

  • Anyone taking other oral medicines at the same time (see Interactions).

  • People avoiding alcohol, for the 40% ethanol tincture.

Critical Safety Point

The monograph tells users to see a doctor if shortness of breath, fever or purulent sputum appears, and to stop self-treating after one week. A dry throat that a lozenge soothes is in scope. A cough with breathlessness, colored sputum or fever is not, and coating the throat can make a serious chest infection feel better than it is.

Recommended Dosages

All figures below are the EMA monograph's posology or the manufacturer's directions for a specific licensed product. They apply to the monograph's two indications only.

Cut herb as tea, throat irritation with dry cough (12 years and older)

1.5 g of cut Iceland moss in 150 ml of boiling water as an infusion, or in cold water as a macerate, 3 to 4 times daily. A macerate is to be used as soon as it is made. A 2021 survey of the German market for the EMA found products directing 1.3 g three to four times daily, which the HMPC judged comparable.

Cut herb as tea, temporary loss of appetite (adults only)

1 to 2 g in 150 ml of water as an infusion or decoction, 3 times daily.

Lozenges with aqueous soft extract (6 years and older under the monograph)

Follow the product's own directions. The 2014 isla moos leaflet (80 mg extract per pastille) says 1 to 2 pastilles several times a day, dissolved slowly in the mouth. That leaflet sets the floor at 4 years, below the EMA's 6-year floor for lozenges; use the EMA floor. For the medical-device isla med akut lozenge, the leaflet allows up to 6 lozenges a day from age 6.

Tincture 1:5 in 40% ethanol (adults only)

The monograph gives 1 to 1.5 ml three times daily (3 to 4.5 ml a day) for adults, for either indication.

Capsules

There is no monograph dose for capsules of powdered thallus, because capsules are not a monograph preparation.

Duration

One week for either indication without medical advice, per the EMA. Product leaflets run differently: the 2014 isla moos leaflet says to see a doctor after 10 days without improvement and allows longer use as needed, while the 2019 isla med akut device leaflet says 3 days.

Timing & Administration

Lozenges work in the mouth, not the stomach

Let each one dissolve slowly; chewing and swallowing shortens the contact time that is the point of the product. Spread lozenges across the day rather than taking several at once.

Tea: hot or cold water changes what you get

Cold water extracts isolichenan; a hot infusion or decoction is needed for lichenan, and the bitter paraconic acids such as protolichesterinic acid also pass into hot-water preparations (Villicaña González, 2026). For throat irritation the monograph allows a hot infusion or a cold macerate. For appetite it names only hot preparations, an infusion or a decoction. Sip the throat tea slowly so it stays in contact with the throat.

Separate from other medicines

The EMA assessment advises taking Iceland moss half an hour to one hour apart from other medicines, because the mucilage could delay their absorption.

With food or without

No interaction with meals is documented. Sugar-sweetened pastilles between meals add up for anyone counting carbohydrates: the 2014 isla moos leaflet gives 0.035 bread units per pastille.

Timeline of Effects

Onset

For the demulcent use, relief is local and starts while the lozenge or tea is in contact with the throat. No study measured onset in minutes, so the honest statement is that the effect is immediate and short-lived, and lasts roughly as long as the coating does.

What the trials ran

  • Kempe 1997: 5 days, from day 1 to day 5 after nasal surgery.

  • Vorberg 1981: 4 days to 3 weeks, open label.

  • Hecker and Völp 2004: 1 to 2 weeks of lozenge use in children.

What counts as a fair trial

The monograph's own limit is one week. If a dry cough or sore throat has not settled in that time, the next step is a medical assessment, not a second week of lozenges.

When to conclude it is not working

If a lozenge gives no relief while it is dissolving, it will not start helping on day 6. For appetite, a week without a change in hunger means the bitter tea has done what it can.

Benefits of Taking Iceland Moss

Relief of mouth and throat dryness after nasal surgery (Kempe 1997)

Kempe, Grüning, Stasche and Hörmann published the only randomized, double-blind trial the EMA assessed, in Laryngo-Rhino-Otologie (1997;76:186 to 188). The abstract reports 61 patients (the EMA assessment counts 63) who had just undergone nasal septum surgery and were breathing only through the mouth while their noses were packed. Three groups received pastilles of different strengths from day 1 to day 5 after the operation. Coating, dryness and inflammation of the mucosa, lymph nodes, tongue findings, hoarseness, sore throat and tolerability were recorded. All three groups improved, and there were no significant differences between the strengths. The authors concluded that the lowest dose, which they gave as 0.48 g per day (10 Isla-Moos lozenges), was sufficient. No adverse effects were reported.

The limitation is built into the design: with no placebo group, the study cannot separate the effect of the lichen from the natural recovery of the mucosa after surgery, or from the effect of sucking any lozenge. A dose comparison in which every dose works equally is also what a placebo response would look like.

Open study in throat and bronchial complaints (Vorberg 1981)

One hundred patients aged 7 to 85 took pastilles with 160 mg of aqueous Iceland moss extract and 5 mg of hogweed extract, 1 to 2 pastilles every 2 to 3 hours, for 4 days to 3 weeks. Results were rated positive in 86%. When the pastilles were used as an add-on in more severe bronchial disease, there was no significant effect. The study was open, uncontrolled and tested a two-herb product.

Surveillance in 3,143 children (Hecker and Völp 2004)

This post-marketing study, run in about 300 mostly pediatric German practices, followed children aged 4 to 12 with upper respiratory complaints taking Isla-Moos (80 mg extract, n = 1,848) or Isla-Mint (100 mg extract, n = 1,295) for 1 to 2 weeks; 61% took 4 to 6 lozenges a day. By the end, investigators rated 39% of the children fully recovered and another 55% improved. The first author was affiliated with Engelhard Arzneimittel, the maker, and without a control group a recovery rate in children with colds mostly measures the natural course of colds. The study's value is its safety data, covered below.

Company consumer test of a 3 mg dry-extract lozenge (Krka, 2026)

Krka employees reported a two-phase market study in Slovenia: an online survey of 820 adults aged 25 to 55, then a 4-week product test in which 123 of 152 recruits completed a questionnaire after using a box of 24 lozenges. Of the 123, 71% rated their relief as good or great and 87% reported improved mucosal hydration. It was not randomized, had no control group and relied entirely on self-report. It is product-satisfaction research, not efficacy evidence.

What the benefit adds up to

A soothing lozenge with a long safety record, supported by one small randomized trial with no placebo arm. That is the evidence base on which the EMA granted traditional-use status, and it is consistent with what a well-made gum-arabic lozenge of any kind might achieve.

Potential Negatives & Side Effects

Adverse reactions in the pediatric surveillance study

In the 3,143 children of Hecker and Völp 2004, 73 adverse events were reported in 57 children (1.8%), mostly attributed to the underlying illness. In 6 children (0.2%), 7 events were judged possibly related to the extract: itching twice, nausea twice, and one case each of abdominal pain, heartburn and burning in the mouth. All resolved during the observation period. The incidence was 1 reaction per 3,008 treatment days (95% confidence interval 1,504 to 7,019).

European pharmacovigilance

The EMA's 2021 periodic review searched EudraVigilance and found 92 case reports mentioning Iceland moss, of which only 4 concerned Iceland moss specifically: a hypersensitivity reaction, vomiting, cough and diarrhea. Except for the hypersensitivity reaction, the events resolved after the product was stopped. Causality could not be established from so few reports.

Contact allergy and photoallergy

Lichen substances are recognized contact allergens. The Thune and Solberg patch-test series described under Who Should Avoid found reactions to Cetraria islandica and possible photoallergy in 6 patients; fumarprotocetraric acid itself produced a reaction in one case.

Excipient effects

Many side effects of Iceland moss products come from what carries the extract. Sucrose-based pastilles deliver about 0.4 g of sugar each. Sorbitol and maltitol versions can cause loose stools and stomach discomfort with excessive use, per the isla med akut leaflet. The tincture contains 40% ethanol.

Delayed absorption of other drugs

A theoretical concern, not a documented one: the EMA added the half-hour to one-hour spacing as a precaution and found no confirmation in humans or animals.

Deficiency Symptoms

What Iceland moss addresses

No deficiency state exists. Lichenan, isolichenan and the lichen acids are not nutrients, and no human tissue requires them. The appetite indication addresses a temporary symptom through bitter taste, not a missing nutrient. Contrast a genuine trace element such as iodine, where intake below need produces a defined disease (goiter) and a measurable fix.

Bottom line

There is nothing to replete. Nobody becomes ill for lack of Iceland moss, and no blood test measures "Iceland moss status."

Toxicity Symptoms

At high intake

At monograph doses the extract itself has a good tolerability record: 1 adverse reaction per 3,008 treatment days in children, and 4 specific EudraVigilance reports across Europe in the 2021 review. The toxicity questions sit elsewhere:

  • Food-scale quantities. Untreated Iceland moss at 50% of the diet killed mice within 4 to 5 days in Airaksinen's 1986 experiments, and a 25% ash-treated diet for 3 months caused proteinuria and kidney tubule damage in rats, attributed by the authors probably to lead in the lichen. Those are dietary loads of tens of percent, far above a tea or lozenge, but they show what the raw material can do when eaten as a staple.

  • Accumulated contaminants. Lead, cadmium, mercury, arsenic, polonium-210 and cesium-137 measured in Iceland moss are covered under Quality, Testing & Adulteration. Lead toxicology itself belongs to this archive's Lead issue.

  • Genotoxicity is untested by standard methods. The EMA found no Ames test and no standard genotoxicity data, and for that reason did not propose Iceland moss for the EU's list of traditional herbal substances. In a 2014 lymphocyte study (Grujičić and colleagues, Cytotechnology), a Cetraria islandica methanol extract increased micronucleus frequency in cultured human lymphocytes, significantly at 50, 100 and 200 micrograms per ml, while a 2011 study (Kotan and colleagues) reported a protective, antigenotoxic effect of a methanol extract at 5 and 10 micrograms per ml against aflatoxin B1. Neither used the water extract people actually take.

  • Usnic acid. This lichen acid caused fulminant liver failure requiring transplant in a 28-year-old woman who took pure usnic acid for weight loss (Durazo, 2004), and it was an ingredient of LipoKinetix, a weight-loss product linked to liver failure. Iceland moss is not a meaningful source: two analyses found none and one found 0.04%. A 2023 chemical study (Manassov and colleagues) did isolate usnic acid from a Cetraria islandica extract, so content can vary by sample. The concern applies mainly if the product is misidentified or substituted with an usnic-acid-rich lichen such as Usnea.

Signs to reduce or stop

  • Itching, rash or skin reactions, especially on sun-exposed skin

  • Nausea, heartburn, abdominal pain or a burning feeling in the mouth

  • Loose stools with sugar-free lozenges

  • Any breathlessness, fever or purulent sputum, which means the cough is outside the monograph's scope

General note

The thallus is a passive collector, so the toxicology of an Iceland moss product depends more on where and when the lichen was harvested than on how much extract is in each lozenge.

How Iceland Moss Works

The demulcent film

Lichenan is a linear beta-glucan with 1,3 and 1,4 links in a ratio of roughly 1:2 to 1:3; one 2018 preparation measured 275 kDa. Isolichenan is an alpha-glucan with a 1,3 to 1,4 ratio of about 55:45 and a much smaller molecule of 6 to 8 kD. Together with other polysaccharides they make up 25 to 50% of the dry thallus. Hydrated, they form a viscous layer that coats the oral and pharyngeal mucosa, reducing the contact of dry air and irritants with sensory nerve endings. This physical action is the basis for the monograph's demulcent indication, and it is why a gum-arabic pastille base, itself a mucilage, suits the extract.

Bitter taste and appetite

Protolichesterinic acid and fumarprotocetraric acid give the lichen its intense bitterness. A 2026 supercritical fluid chromatography method measured protolichesterinic acid at 0.53 to 5.11 mg/g across European samples (Oberosler and colleagues), a nearly tenfold spread. The HMPC's stated rationale for the appetite indication is that bitter taste, and nothing more mechanistic. The EMA assessment cites no human pharmacokinetic data for any Iceland moss constituent.

Immune and anti-inflammatory signaling (laboratory only)

In cultured human dendritic cells, an aqueous extract increased secretion of IL-10 more than IL-12p40, and lichenan reproduced the effect while isolichenan and the lichen acids did not (Freysdottir, 2008). The same extract reduced antigen-induced arthritis in rats when given by subcutaneous injection, a route nobody uses. A high-molecular-weight alpha-glucan named Ci-3 (about 2,000 kD) enhanced phagocytosis in vitro (Olafsdottir, 1999). Protolichesterinic acid inhibits 5-lipoxygenase and reduced DNA synthesis in breast cancer and leukemia cell lines at 1.1 to 24.6 micrograms per ml (Ogmundsdottir, 1998). A 2026 study found paraconic acids stable through a simulated digestion model including a colon phase (Villicaña González), which makes a gut effect conceivable but untested in people.

Why the lichen accumulates contaminants

A lichen has no roots and no cuticle. It takes up water, dissolved minerals and particles directly through the thallus surface from rain, fog and dust. A 2025 study of three lichens found that Cetraria islandica stores much of its water inside its cells and binds cesium-137 intracellularly, making it an efficient long-term accumulator, and found no significant link between thallus activity and soil activity, which points to the air rather than the soil as the main source (Osyczka and colleagues). Fumarprotocetraric acid appears to help the lichen tolerate metals by reducing uptake of metal ions into the cell wall space, which means the lichen survives contamination rather than avoiding it.

Synergistic Supplements

What has actually been combined and studied

  • Hogweed (Heracleum sphondylium). The Vorberg 1981 open study used a pastille of 160 mg Iceland moss extract plus 5 mg hogweed extract in 100 patients. Without a single-herb arm, the contribution of each cannot be separated.

  • Hydrogel complex. The isla med akut device lozenge adds 102 mg of carbomer, xanthan gum and sodium hyaluronate to 80 mg of Iceland moss extract. The added polymers are film formers in their own right; no comparison against Iceland moss alone has been published in the sources we found.

  • Silver salt and sodium hyaluronate. RIPACUT, an Iceland lichen extract combined with silver salt and sodium hyaluronate, showed antioxidant and anti-inflammatory activity in keratinocyte, nasal and intestinal cell cultures (Belvedere, 2023, with a co-author from the manufacturer Shedir Pharma). It is a cell-culture result for a topical product, not a reason to pair supplements.

Other demulcents

Mucilage herbs work by the same physical principle, and the archive's Marshmallow and Slippery Elm issues cover them in their own right. None of the human studies the EMA assessed paired either with Iceland moss.

Bottom line on stacking

There is no evidence that any combination outperforms a plain Iceland moss lozenge, and every added ingredient is another variable in a product whose single-ingredient evidence is already thin.

Interactions & What NOT to Take

Other oral medicines

The only interaction guidance in the EMA assessment is a precaution: take Iceland moss half an hour to one hour apart from other medicines, because the mucilage might delay their absorption. The assessors found no confirmation of this in humans or animals. The practical rule is simple spacing, especially for drugs where timing matters, such as levothyroxine taken on an empty stomach or a short course of an oral antibiotic.

Named drug interactions

None is documented. The EMA reported no interaction studies, the 2021 EudraVigilance search turned up no interaction reports, and there are no cytochrome P450 data for Iceland moss or its lichen acids in humans.

Alcohol-sensitive drugs and the tincture

The 1:5 tincture is 40% ethanol. Anyone taking disulfiram, or anyone who must avoid alcohol for medical or recovery reasons, should use a lozenge or tea instead.

Diabetes medicines and sugar

Ten classic sucrose pastilles a day add about 4.2 g of sugar. That is small, but it is not zero for someone dosing insulin to carbohydrate counts.

What not to substitute

Do not swap Iceland moss for products built on usnic acid or Usnea lichen. Usnic acid is a hepatotoxin with a documented case of liver failure requiring transplant, and it has no place in the Iceland moss monograph.

Quality, Testing & Adulteration

Identity: the sister-species problem

Cetraria islandica has two chemotypes and a near-identical sister species, Cetraria ericetorum. A 2017 study from the University of Iceland (Xu and colleagues, Food Chemistry) showed that UPLC-QToF-MS chemical profiling separates both chemotypes and C. ericetorum, and that the RPB2 DNA barcode distinguishes the two species while the widely used nrITS barcode failed to. A supplier relying on ITS barcoding alone cannot confirm the species. Reindeer lichens (Cladonia species) are another possible mix-up; Airaksinen's famine-food study tested both, and neither was tolerated by mice at 50% of the diet. The name also invites confusion with Irish moss, which is a red seaweed (Chondrus crispus), not a lichen.

Lead and other metals: what has been measured

  • Southern Finland, 1986 (Airaksinen and colleagues): lead 30 mg/kg, cadmium 0.30 mg/kg, mercury 0.075 mg/kg, arsenic 0.76 mg/kg in raw lichen.

  • Italy, published 2017, in print 2018 (Meli and colleagues, Science of the Total Environment): commercial pharmaceutical and food-supplement products from specialty shops had a mean lead concentration of 9.25 mg/kg dry weight, with total arsenic and cadmium below 1 mg/kg. The authors calculated that these levels did not appear to threaten consumers at typical intake but said they should be monitored continuously.

  • European market, 2017 (Giordani and colleagues, Chemosphere): 14 samples of cut, dried thallus from different suppliers, tested for 11 elements by ICP-OES in the raw lichen and in a decoction. Decoction levels were significantly lower, down to negligible health concern, and the differences between raw samples disappeared in the cup. Transfer into the decoction ranged from 2% for copper to 95% for zinc. A 2022 review summarizing the study notes higher values in samples from herbalist shops than from companies. The abstract does not give the lead transfer rate.

The limits those numbers sit against

The European Pharmacopoeia's general Herbal Drugs monograph (1433) caps lead at 5.0 ppm, cadmium at 1.0 ppm and mercury at 0.1 ppm, unless an individual monograph says otherwise. The Iceland moss monograph (1439) does say otherwise: the EMA assessment records its lead limit as 10.0 ppm. For a product sold as a food supplement in the EU, the maximum level for lead is 3.0 mg/kg and for cadmium 1.0 mg/kg, now in Regulation (EU) 2023/915. Read the Italian mean carefully: 9.25 mg/kg pooled medicines and supplements, and a mean does not show which individual products were above or below any limit. What it does show is that the average product in that sample sat just under the pharmacopoeia's elevated ceiling and about three times the supplement level. The European Food Safety Authority's compendium of botanicals of possible concern for human health lists Cetraria islandica.

Radionuclides: polonium-210 and cesium-137

The Italian products carried polonium-210, a natural airborne radionuclide that lichens concentrate, at 132 to 489 Bq/kg, which the authors noted is much higher than UNSCEAR values for leafy vegetables. Cesium-137 is the Chernobyl legacy. Estonian Cetraria islandica measured 6,200 Bq/kg in 1986 in Lahemaa National Park, which the authors called the highest cesium-137 concentration measured in Estonia that year, and 2,100 Bq/kg on Vormsi Island in November 1986 (Martin and colleagues, 1991). The EMA assessment, citing Schilcher (1997), records that after Chernobyl it was difficult to buy Scandinavian Iceland moss below 600 Bq, and that supply improved from 1994. In central Norway, lichens and mosses averaged 4,600 to 6,400 Bq/kg in 1991 to 1994 and below 200 Bq/kg in 2019 to 2022 (Tingstad, 2023). In the Austrian Alps around Bad Gastein, about 17 years after the accident, Cetraria islandica and two other lichens still measured 100 to 1,100 Bq/kg dry weight (Machart, 2007). The ecological half-life of cesium-137 in lichens at those sites averaged 3 to 4 years, so harvest region and year still decide what is in the bag.

What third-party testing covers and misses

A standard heavy-metal panel tests lead, cadmium, arsenic and mercury. It does not test cesium-137, which needs gamma spectrometry, or polonium-210, which needs alpha spectrometry. A certification seal means the product passed the certifier's own panel; it does not mean radionuclides were checked unless the certificate says so.

Questions a buyer can settle before paying

  • Is Cetraria islandica named on the label, and is the product a registered herbal medicine, a medical device or a supplement? The three follow different rules.

  • Where and when was the lichen harvested? Seller silence on region is itself an answer.

  • Will the seller provide a lot-specific certificate with lead in mg/kg? Compare it with 10.0 ppm for a pharmacopoeial drug and 3.0 mg/kg for a supplement.

  • Does that certificate report cesium-137 in Bq/kg? If not, ask.

  • For lozenges, what is the extract amount, the DER and the sugar per piece?

Special Considerations

Children

The age floors differ by form and by document. The EMA sets 6 years for lozenges, 12 for tea and 18 for the tincture or the appetite use. The 2014 isla moos leaflet says 4 years, and the 3,143-child surveillance study enrolled children from age 4. The surveillance data are reassuring on tolerability, but the regulator's floor is the one to use, and a child under 6 should not be given a hard pastille at all.

Pregnancy and breastfeeding

No reproductive toxicity, fertility or lactation data exist. The EMA does not recommend use. Product leaflets that say nothing argues against use are describing an absence of data, not a finding of safety.

Singers, teachers and heavy voice users

Isla leaflets list strained vocal cords among their uses. The supporting data are the general demulcent evidence above; no study has measured voice outcomes with Iceland moss in the sources we reviewed. Hoarseness lasting more than a few weeks needs a laryngeal examination, not a longer lozenge habit.

Foragers

Picking your own Iceland moss in the Alps or Scandinavia means accepting whatever that site has collected. The Bad Gastein lichens still carried up to 1,100 Bq/kg of cesium-137 roughly 17 years after Chernobyl, and an analysis of Italian herbarium lichens collected over more than 25 years linked lead in roadside specimens to the phase-down of leaded gasoline. Roadside and industrial sites are the worst places to gather.

The reindeer food chain

Lichens are winter fodder for reindeer, and the Chernobyl fallout followed that chain into people. At two Norwegian study fields in 1986, the related snow lichen Cetraria nivalis averaged 14,500 and 20,400 Bq/kg (cesium-134 and -137 combined, Gaare, 1987), and Gaare, citing Skogland, reported that meat from most wild reindeer areas exceeded 6,000 Bq/kg. Norway's 2006 radiation protection bulletin gave intervention limits of 3,000 Bq/kg for reindeer and game meat and 600 Bq/kg for other foods; Sweden's marketing limit for reindeer meat is 1,500 Bq/kg. For South Sámi herders in the most contaminated areas, countermeasures cut radiocesium ingestion doses by about 73% over 1986 to 2009 (Skuterud, 2012). The same lichen-to-reindeer pathway is why Iceland moss harvested in the late 1980s was a radiological question at all.

Medicine, device or supplement

The same brand name can cover a registered traditional herbal medicine (with EMA-derived age limits and a one-week duration), a medical device (regulated for a physical film, with its own limits), and in the US, a dietary supplement capsule with no monograph behind it. The federal food-additive listing in the US allows Iceland moss as a natural flavoring in alcoholic beverages only.

Research Status & Evidence Quality

Traditional use, accepted by the regulator

  • Demulcent for mouth and throat irritation with dry cough (EMA monograph, adults, adolescents and children over 6 for lozenges)

  • Temporary loss of appetite (EMA monograph, adults only)

Limited clinical evidence

  • Kempe 1997: randomized, double-blind, three-dose comparison, 61 patients after nasal surgery, 5 days, no placebo; all doses improved equally.

  • Vorberg 1981: open, 100 patients, two-herb pastille, 86% positive ratings, no effect as add-on in severe bronchial disease.

  • Hecker and Völp 2004: uncontrolled surveillance, 3,143 children; strong tolerability data, uninterpretable efficacy data.

Preclinical only

  • Immune modulation (dendritic cells, phagocytosis, complement)

  • Helicobacter pylori inhibition by protolichesterinic acid

  • Antiviral activity against influenza in cell culture

  • Antiproliferative activity in cancer cell lines

  • Antioxidant effects in diabetic rats at 250 to 500 mg/kg of water extract per day (Çolak, 2016)

No evidence

  • Capsules for immunity, lung health, ulcers, weight or detoxification

Research Limitations

  • No placebo-controlled trial is cited in the EMA assessment or its 2021 addendum, and the HMPC rejected well-established use on that basis.

  • The EMA's 2021 periodic review screened a PubMed search returning 207 results for 2013 to 2021 and found no new clinical efficacy or safety data.

  • The largest dataset had a first author from the manufacturer, and the most recent was run by another manufacturer's employees.

  • Every human study used an aqueous lozenge extract; none tested tea, tincture, syrup or capsules.

  • Lichen acid content varies widely between samples, protolichesterinic acid nearly tenfold in one 2026 analysis, and no study related its dose to an outcome.

  • None of the clinical studies reported the metal or radionuclide content of the material used.

Summary & Key Takeaways

Bottom Line

Iceland moss is a lichen whose 25 to 50% polysaccharide content makes a soothing, mucilaginous lozenge or tea, and the EU accepts it only as a traditional remedy for dry, irritated throats with dry cough and for short-term appetite loss. Its human evidence is one small randomized trial without placebo, an open study and a large surveillance study that mostly documents tolerability. Because the lichen has no cuticle, its real risk profile is set by where and when it was harvested, which is information most labels leave out.

Key Safety Points

  • Use the EMA age floors: 6 years for lozenges, 12 for tea, 18 for tincture or appetite use.

  • Stop after one week, and see a doctor sooner for breathlessness, fever or purulent sputum.

  • Not recommended in pregnancy or breastfeeding for lack of data.

  • Space it half an hour to one hour from other oral medicines.

  • Skin reactions on sun-exposed areas may signal lichen photoallergy.

  • Ask for a lot certificate with lead and cesium-137 results; standard metal panels omit radionuclides.

Special Note

The reason to read an Iceland moss label closely has more to do with the lichen's biology than with the extract. A lozenge from a documented, tested harvest is a low-risk comfort measure that produced 1 reaction per 3,008 treatment days in children. A bag of cut thallus with no stated origin and no certificate is a sample of whatever fell on that hillside, and nobody has told you what that was.

Forwarded this, or reading it on the web? to get the next breakdown.

Researched and drafted with AI assistance. Every claim verified against primary sources and human-reviewed before publication. Last reviewed: November 7, 2026. Corrections: reply to any issue.

This issue is for education only and is not medical advice. If you take any medication or live with a diagnosed condition, talk with your clinician before adding or changing a supplement.

Get the next ingredient breakdown free

The Complete Ingredient Breakdown takes one supplement ingredient per issue: what it does, what the research shows, and what the label won't tell you. Free by email, unsubscribe anytime.

Subscribe free

Is Iceland Moss safe? Common questions

Is Iceland Moss safe for everyone?

Who may consider it: Adults and older children with a dry, irritated throat and a dry cough This is the monograph population. The typical triggers named on Isla leaflets are dry heated or air-conditioned air, heavy voice use by singers and speakers, mouth… Who should avoid it: Contraindications Hypersensitivity to Iceland moss or any lichen. This is the only contraindication in the EMA assessment. Children under 6 years for lozenges, under 12 years for the tea, and under 18 years for the…

What are possible side effects of Iceland Moss?

Adverse reactions in the pediatric surveillance study In the 3,143 children of Hecker and Völp 2004, 73 adverse events were reported in 57 children (1.8%), mostly attributed to the underlying illness. In 6 children (0.2%), 7 events were judged possibly related to the extract: itching twice, nausea twice, and one case each of abdominal pain, heartburn and…

Does Iceland Moss interact with medications or other supplements?

Other oral medicines The only interaction guidance in the EMA assessment is a precaution: take Iceland moss half an hour to one hour apart from other medicines, because the mucilage might delay their absorption. The assessors found no confirmation of this in humans or animals. The practical rule is simple spacing, especially for drugs where timing matters…

New in the library
  • Uranium
  • Hyssop
  • Hydrangea Root
  • Houttuynia
  • Honeybush

The Nutrient Wise app checks Iceland Moss against the medications you take and warns you before you scan a supplement that could interact. It is free to start (5 scans a month, no card): App Store · Google Play.


Medical disclaimer: This page is informational, not medical advice. Talk to a licensed healthcare provider before starting any supplement, especially if you take medications or have a chronic condition. See our privacy policy for how we handle your data inside the app.

Privacy Policy Terms of Service Library

© Nutrient Wise. All rights reserved.